Skip to main content
. 2019 Feb 22;4(1):e000246. doi: 10.1136/tsaco-2018-000246

Table 2.

Primary outcomes

Study ID Antibiotic group Placebo group
Total Empyema Pneumonia Total Empyema Pneumonia
Grover13 38 1 4 37 6 13
Stone6 40 1 0 43 2 5
LeBlanc5 26 0 1 26 1 1
Mandal14 40 0 0 40 1 0
LoCurto15 30 0 0 28 5 4
Brunner20 44 0 1 46 6 3
Cant16 57 0 7 56 5 19
Nichols19 63 0 0 56 4 3
Gonzalez17 71 0 0 68 2 2
Maxwell7 153 2 12 71 4 2
Villegas Carlos18 63 3 N/A 63 5 N/A
Heydari12 54 0 2 50 1 4
Total 679 7 (1%) 27 (4.4%) 584 42 (7.2%) 56 (10.7%)

Values in parenthesis are percentages.